Pfizer

Pfizer Inc.

Logo used since 2021
Company type	Public
Traded as	NYSE: PFE S&P 100 component S&P 500 component
Industry	Pharmaceutical Biotechnology
Founded	1849; 176 years ago (1849) in New York City
Founders	Charles Pfizer Charles F. Erhart
Headquarters	The Spiral, New York City , US
Area served	Worldwide
Key people	Albert Bourla (chairman and CEO)
Products	Pharmaceutical drugs vaccines
Revenue	US$63.6 billion (2024)
Operating income	US$10.6 billion (2024)
Net income	US$8.02 billion (2024)
Total assets	US$219.4 billion (2024)
Total equity	US$176.2 billion (2024)
Number of employees	c. 88,000 (2024)
Website	www.pfizer.com
Footnotes / references [1]

Former corporate logos (until 2021).

Pfizer Inc. (/ˈfaɪzər/ FY-zər)^[2] is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer (1824–1906) and Charles F. Erhart (1821–1891), Pfizer is one of the oldest pharmaceutical companies in North America.

Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in 2023 revenues), a pneumococcal conjugate vaccine ($6 billion in 2023 revenues), palbociclib ($4 billion in 2023 revenues), and tafamidis ($3 billion in 2023 revenues).^[3] In 2023, 46% of the company's revenues came from the United States, 6% came from Japan, and 48% came from other countries.^[3]

Pfizer has been a publicly traded company for nearly a century, making its debut on the New York Stock Exchange in 1942 under the ticker symbol PFE. Since then, its stock has seen ups and downs, influenced by new drug launches, regulatory shifts, and changing market demand for its medicines and vaccines. As a key player in the healthcare industry, Pfizer is part of major stock indices like the S&P 100 and S&P 500, with major institutional investors such as Vanguard and State Street holding significant stakes.^[4][5]

Pfizer is one of the top pharmaceutical companies in the United States, with a market capitalization of $150.35 billion as of December 31, 2024. It ranks fifth among U.S. pharma companies. As of 2024, the company holds the 69th position on the Fortune 500 list.^[6][7]